Search research articles
Contact Us
Filters
Showing results (91-100 of 136) with videos related to
Page
of 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2016
Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic
Christopher B Weldon, Arin L Madenci, Sosipatros A Boikos, et al.
Cancer
|
September 12, 2018
The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas
Steven G DuBois, Theodore W Laetsch, Noah Federman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 15, 2010
Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: results of a pooled analysis from United States and European groups
Andrea Ferrari, Rosalba Miceli, Annie Rey, et al.
Cancer Research
|
February 27, 2021
The Common Germline <i>TP53-R337H</i> Mutation Is Hypomorphic and Confers Incomplete Penetrance and Late Tumor Onset in a Mouse Model
John R Jeffers, Emilia M Pinto, Jerold E Rehg, et al.
Cancer
|
December 28, 2020
Pain and functional outcomes in adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort study
Ingrid Tonning Olsson, Nicole M Alberts, Chenghong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 24, 2017
A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma
Sara M Federico, M Beth McCarville, Barry L Shulkin, et al.
JAMA Oncology
|
March 25, 2016
Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic
Sosipatros A Boikos, Alberto S Pappo, J Keith Killian, et al.
The Lancet. Oncology
|
April 3, 2018
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
Theodore W Laetsch, Steven G DuBois, Leo Mascarenhas, et al.
International Journal of Cancer
|
June 21, 2017
A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy
Fariba Navid, Victor M Santana, Michael Neel, et al.
Cancers
|
September 13, 2025
ESFT13: A Phase II Study Evaluating the Addition of Window and Maintenance Therapy to a Standard Chemotherapy Backbone for the Treatment of High-Risk Ewing Sarcoma
Jessica Gartrell, Fariba Navid, Xiaomeng Yuan, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 136) with videos related to
Sort By:
Page
of 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2016
Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic
Christopher B Weldon, Arin L Madenci, Sosipatros A Boikos, et al.
Cancer
|
September 12, 2018
The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas
Steven G DuBois, Theodore W Laetsch, Noah Federman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 15, 2010
Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: results of a pooled analysis from United States and European groups
Andrea Ferrari, Rosalba Miceli, Annie Rey, et al.
Cancer Research
|
February 27, 2021
The Common Germline <i>TP53-R337H</i> Mutation Is Hypomorphic and Confers Incomplete Penetrance and Late Tumor Onset in a Mouse Model
John R Jeffers, Emilia M Pinto, Jerold E Rehg, et al.
Cancer
|
December 28, 2020
Pain and functional outcomes in adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort study
Ingrid Tonning Olsson, Nicole M Alberts, Chenghong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 24, 2017
A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma
Sara M Federico, M Beth McCarville, Barry L Shulkin, et al.
JAMA Oncology
|
March 25, 2016
Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic
Sosipatros A Boikos, Alberto S Pappo, J Keith Killian, et al.
The Lancet. Oncology
|
April 3, 2018
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
Theodore W Laetsch, Steven G DuBois, Leo Mascarenhas, et al.
International Journal of Cancer
|
June 21, 2017
A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy
Fariba Navid, Victor M Santana, Michael Neel, et al.
Cancers
|
September 13, 2025
ESFT13: A Phase II Study Evaluating the Addition of Window and Maintenance Therapy to a Standard Chemotherapy Backbone for the Treatment of High-Risk Ewing Sarcoma
Jessica Gartrell, Fariba Navid, Xiaomeng Yuan, et al.
Page
of 14